News Service

late-breaking news in healthcare

FDA News Briefs for Thursday, March 21, 2019

March 21, 2019 News Service

These Food and Drug Administration (FDA) developments came in this week.

ACC/AHA Guideline Update: Primary Prevention of Cardiovascular Disease

March 20, 2019 News Service

The American College of Cardiology and American Heart Association (ACC/AHA) have issued updated guidance on the primary prevention of cardiovascular disease (CVD) in adults.

FDA Safety Alerts for Wednesday, March 20, 2019

March 20, 2019 News Service

The Food and Drug Administration (FDA) has issued the following safety alerts.

FDA News Briefs for Monday, March 18, 2019

March 18, 2019 News Service

These Food and Drug Administration (FDA) developments came in last week.

FDA News Briefs for Friday, March 15, 2019

March 15, 2019 News Service

These Food and Drug Administration (FDA) developments came in this week.

FDA Expands Indications for Dupixent

March 13, 2019 News Service

The Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Dupixent (dupilumab; Sanofi and Regeneron Pharmaceuticals Inc.) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 to 17 years.

FDA News Briefs for Monday, March 11, 2019

March 11, 2019 News Service

These Food and Drug Administration (FDA) developments came in last week.

Updated Safety Communication: Wearable Cardioverter Defibrillators

March 8, 2019 News Service

The Food and Drug Administration (FDA) provided an update on a recall pertaining to the LifeVest 4000 (Zoll Manufacturing Corporation) and its potential to not deliver treatment to patients wearing the cardioverter defibrillator.

FDA Approves Intranasal Esketamine for Treatment-Resistant Depression

March 7, 2019 News Service

On March 5, 2019, the Food and Drug Administration (FDA) approved a new drug application for Spravato (esketamine; Janssen Pharmaceuticals Inc.) for the treatment of treatment-resistant depression in adults.

FDA Safety Alerts

March 6, 2019 News Service

The Food and Drug Administration (FDA) has issued the following safety recalls.